MSTN and proximal spinal muscular atrophy: However, a recent report shows that serum and muscle biopsies from SMA patients display decreased expression of myostatin and increased levels of follistatin (Mariot et al., 2017), suggesting that additional mechanistic insight in the relevance of targeting this pathway for SMA therapy is required.